UPDATE: JP Morgan Downgrades Walgreens To Neutral, Lowers Target To $63 Notes 'With WBA expected to provide FY20 guidance with F4Q1 results on Monday 10/28, we believe adjusted operating profit growth will continue to remain challenged in the near term'